REBECCA SCADUTO: Open Payments
NPI 1518444108 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 31 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $328 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $141 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Alkermes, Inc. | 2 | $39 |
| Corium, LLC | 3 | $35 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Vertical Pharmaceuticals, LLC | 1 | $24 |
| Lundbeck LLC | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
Products named: VRAYLAR, REXULTI, Auvelity, LYBALVI, Azstarys, Qelbree, SPRAVATO, Relexxii.
Industry payments across TX — which companies pay providers there.
